Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Uncovering a novel function for NRXN1a using cellular models of early hindbrain neurodevelopment

Project description

Molecular origins of neurodevelopmental disorders

Neurodevelopmental disorders such as autism spectrum disorder, schizophrenia and intellectual disability affect millions of people worldwide. However, the underlying molecular mechanisms remain poorly understood. The protein neurexin1a (NRXN1a) functions at neuronal synapses and has been strongly associated with these conditions. However, its potential involvement during the earliest stages of brain cell development has never been investigated. With the support of the Marie Skłodowska-Curie Actions programme, the NeurXium project will study NRXN1a function during early neural differentiation using stem cell-derived models and cerebellar organoids. The goal is to advance our understanding of the molecular origins of neurodevelopmental disorders and contribute to the development of more precise diagnostic and therapeutic approaches.

Objective

Neurexin1a (NRXN1a) is involved in the pathology of multiple neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), schizophrenia, and intellectual disability. Until now, the mechanism has been mainly attributed to its function at neuronal synapses. Here, I aim to break new ground by uncovering the function of NRXN1a in the early stage of neural differentiation of induced pluripotent stem cells (iPSCs), where a short peak of its expression has been identified. Intriguingly, despite the strong associations of NRXN1a with NDDs, such a study is missing.
To elucidate the role of NRXN1a at the early stage of neural differentiation, I will use two different complementary iPSC-derived cellular models of hindbrain neural development from healthy controls, an ASD-diagnosed patient with a biallelic mutation in NRXN1a, and a CRISPR-edited NRXN1a-deficient iPSC line, enabling simultaneous investigation of distinct aspects of the NRXN1a-deficient phenotype. Using this approach, I first aim to decipher the molecular mechanisms of NRXN1a function and its involvement in the regulation of intracellular calcium levels. Next, I aim to model the outcomes of NRXN1a deficiency in a disease-relevant setup using cerebellar organoids.
Together, this project will advance our understanding of the function of NRXN1a in the early hindbrain differentiation. It will help elucidate the structural and functional abnormalities observed in ASD-affected cerebella and enable a more precise interpretation of phenotypes observed in NRXN1a-deficient patients. Since increasing evidence suggests that the clinical manifestations of various NDDs may be underlined by a common molecular mechanism, the results have the potential to be beneficial also for other studies on NDDs.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

LUNDS UNIVERSITET
Net EU contribution
€ 236 340,00
Address
Paradisgatan 5c
22100 Lund
Sweden
Region
Södra Sverige Sydsverige Skåne län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data